IMMUNOVANT INC - Security Detail

Period	Total Value	Value Change	Total Holders	Holder Change
2024-06-30	$1.97B	-	198	-
2024-09-30	$2.24B	+13.7%	184	-7.1%
2024-12-31	$1.98B	-11.9%	180	-2.2%

Institution	Value	Shares	% of Portfolio
ALPINE GLOBAL MANAGEMENT, LLC	$53.5M	2,158K	12.6%
STEMPOINT CAPITAL LP	$27.7M	1,118K	6.9%
DEEP TRACK CAPITAL, LP	$148.6M	6,000K	5.5%
ADAR1 CAPITAL MANAGEMENT, LLC	$19.5M	787K	3.9%
TWO SEAS CAPITAL LP	$37.4M	1,511K	3.2%
PROSIGHT MANAGEMENT, LP	$7.6M	305K	2.1%
BOXER CAPITAL MANAGEMENT, LLC	$20.4M	825K	1.7%
PERCEPTIVE ADVISORS LLC	$53.0M	2,139K	1.5%
ARMISTICE CAPITAL, LLC	$95.9M	3,870K	1.3%
TYRO CAPITAL MANAGEMENT LLC	$3.8M	151K	1.2%
IKARIAN CAPITAL, LLC	$7.4M	300K	1.0%
REDMILE GROUP, LLC	$14.2M	571K	1.0%
LOGOS GLOBAL MANAGEMENT LP	$7.4M	300K	0.9%
ROCK SPRINGS CAPITAL MANAGEMENT LP	$22.5M	909K	0.9%
KNOTT DAVID M JR	$2.3M	92K	0.8%
DAFNA CAPITAL MANAGEMENT LLC	$2.7M	107K	0.7%
ARMISTICE CAPITAL, LLC	$33.4M	1,350K	0.5%
BAKER BROS. ADVISORS LP	$42.3M	1,707K	0.5%
HOOD RIVER CAPITAL MANAGEMENT LLC	$28.4M	1,145K	0.4%
RHENMAN & PARTNERS ASSET MANAGEMENT AB	$3.6M	145K	0.4%
AFFINITY ASSET ADVISORS, LLC	$2.5M	100K	0.3%
PLATINUM INVESTMENT MANAGEMENT LTD	$5.0M	202K	0.3%
EFG ASSET MANAGEMENT CORP.	$1.8M	73K	0.3%
EMERALD MUTUAL FUND ADVISERS TRUST	$3.9M	156K	0.2%
EMERALD ADVISERS, LLC	$6.1M	244K	0.2%

Ticker	Exchange	Security	Similarity Score	Common Holders	Total Holders
IKT	US	INHIBIKASE THERAPEUTICS INC	0.065	2	31
HLXB	US	HELIX ACQUISITION CORP II	0.063	2	32
ABVX	US	ABIVAX SA-ADR	0.043	2	46
CNTA	US	CENTESSA PHARMACEUTICALS-ADR	0.038	4	106
CTNM	US	CONTINEUM THERAPEUTICS INC-A	0.034	2	59
GLPG	US	GALAPAGOS NV-SPON ADR	0.027	2	75
JSPR	US	JASPER THERAPEUTICS INC	0.024	2	83
SYRE	US	SPYRE THERAPEUTICS INC	0.024	3	126
MGTX	US	MEIRAGTX HOLDINGS PLC	0.021	2	95
ETNB	US	89BIO INC	0.021	3	146
MLYS	US	MINERALYS THERAPEUTICS INC	0.019	2	104
RCKT	US	ROCKET PHARMACEUTICALS INC	0.019	4	210
ELVN	US	ENLIVEN THERAPEUTICS INC	0.019	2	107
ALDX	US	ALDEYRA THERAPEUTICS INC	0.019	2	107
PTGX	US	PROTAGONIST THERAPEUTICS INC	0.018	4	221
ROIV	US	ROIVANT SCIENCES LTD	0.018	5	277
CLMT	US	CALUMET INC	0.018	2	112
AMLX	US	AMYLYX PHARMACEUTICALS INC	0.018	2	113
MRUS	US	MERUS NV	0.016	3	182
NMRA	US	NEUMORA THERAPEUTICS INC	0.016	2	124
KALV	US	KALVISTA PHARMACEUTICALS INC	0.016	2	124
EWTX	US	EDGEWISE THERAPEUTICS INC	0.015	3	195
JANX	US	JANUX THERAPEUTICS INC	0.015	3	204
NUVL	US	NUVALENT INC-A	0.015	3	205
ABUS	US	ARBUTUS BIOPHARMA CORP	0.014	2	139